LeMaitre Vascular Inc. (LMAT)
NASDAQ: LMATHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
LMAT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.81B
- P/E (TTM)
- 27.83
- Forward P/E
- 24.95
- EPS (TTM)
- $2.85
- Dividend yield
- 1.13% ($0.90)
- Ex-dividend date
- Aug 20, 2026
- 52-week range
- 78.22 – 118.01
- Day range
- 78.58 – 80.47
- Volume / Avg
- 218.31K / 328.65K
- Beta
- —
- Shares outstanding
- 22.87M
- Next earnings
- Nov 5, 2026
52-week range
LMAT stock today
LeMaitre Vascular (LMAT) closed at $79.31 on Oct 7, up 0.33% (+$0.26), versus the S&P 500's 0.22% decline. At this level, LMAT sits near the bottom of its 52-week range of $78.22 to $118.01: 32.8% below the high, set on Apr 14, 2026 and 1.4% above the low. LMAT is down 2.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 8.6%.
LeMaitre Vascular trades at 27.8x its trailing twelve-month earnings per share of $2.85. Its forward P/E of 25.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. LeMaitre Vascular's next earnings report is expected on Nov 5, 2026. LeMaitre Vascular pays an annual dividend of $0.90 per share, a 1.13% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About LeMaitre Vascular
Company profileLeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. George W. LeMaitre
- Headquarters
- Burlington, MA
- Employees
- 646
- IPO year
- 2006
- Website
- lemaitre.com
Analyst forecast
ForecastConsensus (8 analysts)
buy
Avg. price target
$107.00+34.91%
- Strong buy 2
- Buy 2
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.69
Dividends
Dividend history- Annual dividend
- $0.90
- Dividend yield
- 1.13%
- Last payment
- $0.25
- Ex-dividend date
- Aug 20, 2026
LeMaitre Vascular peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NVCRNovoCure Limited | 14.66 | -2.07% | $1.71B | vs LMAT |
| XRAYDENTSPLY SIRONA Inc. | 8.54 | +0.23% | $1.70B | vs LMAT |
| INSPInspire Medical Systems Inc. | 67.45 | -1.10% | $1.95B | vs LMAT |
| ATECAlphatec Holdings Inc. | 10.25 | -2.75% | $1.58B | vs LMAT |
| KMTSKestra Medical Technologies Ltd. | 26.49 | -2.25% | $1.58B | vs LMAT |
| UFPTUFP Technologies Inc. | 292.87 | -3.30% | $2.27B | vs LMAT |
| DRTSAlpha Tau Medical Ltd. | 14.25 | -1.59% | $1.32B | vs LMAT |
| TNDMTandem Diabetes Care Inc. | 15.84 | -1.98% | $1.10B | vs LMAT |
Indexes, lists and sector
Appears in lists
LeMaitre Vascular stock FAQ
What is LeMaitre Vascular's stock price today?
LMAT last traded at $79.31 as of Oct 7, 4:00 PM EDT, up 0.33% on the day. Prices are delayed at least 15 minutes.
Does LeMaitre Vascular pay a dividend?
Yes. LeMaitre Vascular pays $0.90 per share annually, a 1.13% yield. The most recent dividend of $0.25 had an ex-dividend date of Aug 20, 2026.
When is LeMaitre Vascular's next earnings date?
LeMaitre Vascular is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.69.
What is LMAT's P/E ratio?
LMAT trades at a trailing P/E ratio of 27.83 and a forward P/E of 24.95.
Who is LeMaitre Vascular's CEO?
Mr. George W. LeMaitre is the chief executive officer of LeMaitre Vascular Inc., which has about 646 employees.
What is the LMAT 52-week high?
The 52-week high for LMAT is $118.01 and the 52-week low is $78.22. The stock is currently 32.8% below its high.